FDA-Drug2023-10-25Class II
Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Pine Pharmaceuticals, LLC
Hazard
Lack of Assurance of Sterility
Sold states
Nationwide within the United States
Affected count
860 syringes
Manufactured in
355 Riverwalk Pkwy, N/A, Tonawanda, NY, United States
Products
Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0064-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief